扩散峰度成像与动态对比增强MRI预测乳腺癌预后因素及分子亚型的比较
回顾性分析130例病理确诊乳腺癌患者的DKI与DCE-MRI数据,比较两种模型预测预后因素和分子亚型的价值。Ktrans预测NPI和MK识别Ki-67状态的诊断效能分别优于其他单参数,联合模型鉴别luminal A/B与非luminal亚型的AUC显著高于单参数。
要点
- Ktrans预测NPI的AUC显著高于Kep和MK(p=0.038和0.0217)。
- MK识别Ki-67表达状态的诊断效能优于Ktrans和Kep(p=0.0097和0.0008)。
- 联合模型(MD+MK+Ktrans+Ve)鉴别luminal A/B与非luminal亚型的AUC显著高于各单参数。
核心结论
- DCE-MRI的Ktrans和DKI的MK在预测乳腺癌预后因素方面表现出良好的诊断效能,联合DCE-MRI与DKI模型可提高预测乳腺癌基因型的效率。
研究设计与样本
- 回顾性研究,纳入130例经病理确诊的乳腺癌女性患者,分析其DKI和DCE-MRI数据,由两名放射科医师独立评估DKI模型的MD和MK以及DCE-MRI模型的Ktrans、Kep和Ve,采用ROC曲线分析诊断效能。
诊断标准与关键数值
- 高分级NPI组(NPI≥3.4)的MK、Ktrans和Kep值显著高于低分级NPI组(NPI<3.4)(p<0.01)。
- Ktrans预测NPI的AUC显著大于Kep和MK(p=0.038和0.0217)。
- 高Ki-67表达组(≥14%)的Ktrans、Kep和MK值高于低Ki-67表达组(<14%)(p<0.05),MK识别Ki-67表达状态的诊断效能优于Ktrans和Kep(p=0.0097和0.0008)。
- 联合模型(MD+MK+Ktrans+Ve)鉴别luminal A/B与非luminal亚型的AUC显著高于各单参数(p=0.003、<0.001、0.001和<0.001)。
- HER2阳性组的MD和Ve值高于其他亚型组(p<0.05),Ve的敏感度为100%;Ve识别三阴性亚型的AUC显著高于MD(p=0.048)。
临床应用与阅片要点
- Ktrans可用于预测乳腺癌NPI分级,MK可用于识别Ki-67表达状态。
- 联合DCE-MRI与DKI模型可提高预测乳腺癌基因型的效率。
- Ve识别三阴性亚型时敏感度达100%,Ve的AUC显著高于MD(p=0.048)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the clinical value of diffusional kurtosis imaging (DKI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) for predicting genotypes and prognostic factors of breast cancer.
MATERIALS AND METHODS: A total of 130 female patients with pathologically-confirmed breast cancer and DKI and DCE-MRI data were reviewed retrospectively. Two radiologists independently evaluated mean diffusivity (MD) and mean kurtosis (MK) for the DKI model and volume transfer constant (Ktrans), reverse rate constant (Kep), and extracellular extravascular volume ratio (Ve) for the DCE-MRI model for post-processing analyses. Receiver operating characteristic (ROC) curves were used to analyse the diagnostic efficacies.
RESULTS: MK, Ktrans, and Kep values were significantly higher in the high-grade Nottingham prognostic index (NPI) group (NPI ≥ 3.4) than in the low-grade NPI group (NPI < 3.4) (p < 0.01). The Ktrans had significantly greater area under ROC curve (AUC) than Kep and MK in predicting the NPI (p = 0.038 and 0.0217, respectively). Higher Ktrans, Kep, and MK values were observed in the high Ki-67 expression (≥14%) group than in the low Ki-67 expression (<14%) group (p < 0.05). Moreover, the MK value had better diagnostic performance than the Ktrans and Kep values in identifying Ki-67 expression status (p = 0.0097 and 0.0008, respectively). The combined model (MD + MK + Ktrans + Ve) had a significantly higher AUC than the single parameters for differentiating between luminal A/B and non-luminal subtypes (p = 0.003, < 0.001, 0.001, and < 0.001, respectively). The Human epidermal growth factor receptor 2-positive group had higher MD and Ve values than the other subtype groups (p < 0.05), and the Ve had a sensitivity of 100%. Moreover, the Ve AUC was significantly higher than that for MD in the identification of the triple-negative subtype (p = 0.048).
CONCLUSION: Ktrans of DCE-MRI and MK of DKI demonstrated good diagnostic performance in predicting the prognostic factors of breast cancer. Additionally, the combination of the DCE-MRI and DKI models can improve the efficiency of predicting breast cancer genotypes.
引用
- Wang, Lv, Xun, et al. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer. Eur J Radiol. 2022. PMID: 35679701. doi:10.1016/j.ejrad.2022.110392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。